This inventor holds 1 USPTO granted patent. Top assignee: Qilu Antibiotics Pharmaceutical Co. Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Michao Shi: Innovator in Cephalosporin Intermediate Production
Introduction
Michao Shi is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin intermediates. His work has implications for the production of antibiotics, which are crucial in modern medicine.
Latest Patents
One of Michao Shi's key patents is for the "Crystal of cephalosporin intermediate 7α-methoxy cephalothin and method for preparing same." This invention relates to a crystal of 7α-methoxy cephalothin, which is characterized by its high purity and stability. The preparation method is simple and cost-effective, making it suitable for industrial production. The crystal exhibits specific absorption peaks when subjected to Cu-Kα radiation and X-ray powder diffraction, indicating its unique properties.
Career Highlights
Michao Shi is associated with Qilu Antibiotics Pharmaceutical Co. Ltd., where he has been instrumental in advancing antibiotic production techniques. His innovative approach has led to the development of methods that are not only efficient but also environmentally friendly. His patent portfolio includes 1 patent, showcasing his commitment to innovation in the pharmaceutical industry.
Collaborations
He has worked alongside talented colleagues such as Meiju Fan and Chuanshan Hou, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Michao Shi's contributions to the field of pharmaceuticals, particularly through his patent on cephalosporin intermediates, highlight his role as an important inventor. His work not only advances antibiotic production but also sets a standard for future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile